» Articles » PMID: 2791214

Dual Inhibitory Effect of Bredinin

Overview
Date 1989 Jul 1
PMID 2791214
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Bredinin inhibition of cell growth was investigated in the mouse lymphoma cell line L5178Y. Bredinin caused the accumulation of IMP and the reduction of XMP. It was converted to the 5'-phosphate within the cells. Bredinin 5'-phosphate but not bredinin competitively inhibited both IMP dehydrogenase and GMP synthetase. Thus the inhibition of cell growth is probably due to bredinin 5'-phosphate, which inhibits the consecutive enzyme reactions IMP dehydrogenase and GMP synthetase. These inhibitions result in the accumulation of IMP and the reduction of XMP.

Citing Articles

Mizoribine Promotes Molecular Chaperone HSP60/HSP10 Complex Formation.

Miura A, Narita Y, Sugawara T, Shimizu H, Itoh H Int J Mol Sci. 2024; 25(12).

PMID: 38928158 PMC: 11203801. DOI: 10.3390/ijms25126452.


Immunosuppressive Agent Options for Primary Nephrotic Syndrome: A Review of Network Meta-Analyses and Cost-Effectiveness Analysis.

Nagai K Medicina (Kaunas). 2023; 59(3).

PMID: 36984602 PMC: 10054564. DOI: 10.3390/medicina59030601.


Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap.

Halama A, Suhre K Cancers (Basel). 2022; 14(3).

PMID: 35158820 PMC: 8833671. DOI: 10.3390/cancers14030553.


Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.

Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N Cancers (Basel). 2019; 11(9).

PMID: 31514446 PMC: 6770829. DOI: 10.3390/cancers11091346.


Usefulness of mizoribine administration in children with frequently relapsing nephrotic syndrome, and the relationship between pharmacokinetic parameters and efficacy: a multicenter prospective cohort study in China.

Xia Z, Gao Y, Rong L, Dang X, Shen Q, Jiang X World J Pediatr. 2019; 15(3):262-269.

PMID: 30864060 DOI: 10.1007/s12519-019-00241-7.